Mer­ck de­lays $11.5B Ac­celeron buy­out to give an­titrust watch­dog 'ad­di­tion­al time for re­view'

Mer­ck’s $11.5 bil­lion Ac­celeron Phar­ma buy­out may not hap­pen quite as soon as the Ke­nil­worth, NJ-based phar­ma com­pa­ny had hoped.

On Fri­day, Mer­ck re­vealed that it had tem­porar­i­ly with­drawn its pre­merg­er no­ti­fi­ca­tion and re­port form — which pro­vides more in­for­ma­tion about large M&A deals to the Fed­er­al Trade Com­mis­sion and De­part­ment of Jus­tice be­fore they oc­cur — to al­low the FTC more time for re­view. The com­pa­ny says it plans to re­file to­day, or soon af­ter, in the hopes that it can still seal the deal by the end of Q4.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER